| Matei T Andreoiu, MD | |
|
8725 N Wickham Rd Ste 202, Melbourne, FL 32940-2240 | |
| (321) 434-9528 | |
| (321) 434-9529 |
| Full Name | Matei T Andreoiu |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 21 Years |
| Location | 8725 N Wickham Rd Ste 202, Melbourne, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144477795 | NPI | - | NPPES |
| 102487900 | Medicaid | FL | |
| KP392 | Other | FL | MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | ME10755 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Viera Hospital | Melbourne, FL | Hospital |
| Cape Canaveral Hospital | Cocoa beach, FL | Hospital |
| Holmes Regional Medical Center | Melbourne, FL | Hospital |
| Palm Bay Hospital | Palm bay, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Health First Medical Group Llc | 7416100672 | 713 |
News Archive
iMDsoft®, a global leader in hospital-wide clinical information systems, and Dominion, a leading provider of technology solutions in Spain and Latin America, have announced an agreement whereby Dominion will distribute iMDsoft's MetaVision® suite of solutions in Spain.
One of the common side effects of HIV and AIDS is neurocognitive impairments - changes in how fast a person can process information, pay attention, multi-task and remember things - yet there are no adequate tests to screen patients for these problems, according to a new study out of St. Michael's Hospital.
Now, China is ready to run its large-scale phase III clinical trial of its novel coronavirus candidate in the United Arab Emirates (UAE). Over a dozen experimental vaccines are being trialed across the globe, but China's vaccine is the first one to proceed to phase III human trials.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced the Company has completed business negotiations with one of the U.S. Government's top national security research institutions regarding the acquisition of rights to the Integrated Optical Biosensor System (IBOS) technology developed by the laboratory personnel. Biomagnetics Diagnostics plans to utilize this technology to enter the significantly underserved market for handheld biosensors capable of detecting a broad range of disease-causing viruses, bacteria and fungi.
Ornim, Inc. is pleased to announce the receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the CerOx 3210F monitor. Additionally to its previous clearance for non-invasive monitoring of regional hemoglobin oxygen saturation in the brain or skeletal muscle, the CerOx 3210F is now also intended for use as a non-invasive monitor of blood flow in tissue of adults.
› Verified 2 days ago
| Entity Name | Health First Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750626495 PECOS PAC ID: 7416100672 Enrollment ID: O20130122000135 |
News Archive
iMDsoft®, a global leader in hospital-wide clinical information systems, and Dominion, a leading provider of technology solutions in Spain and Latin America, have announced an agreement whereby Dominion will distribute iMDsoft's MetaVision® suite of solutions in Spain.
One of the common side effects of HIV and AIDS is neurocognitive impairments - changes in how fast a person can process information, pay attention, multi-task and remember things - yet there are no adequate tests to screen patients for these problems, according to a new study out of St. Michael's Hospital.
Now, China is ready to run its large-scale phase III clinical trial of its novel coronavirus candidate in the United Arab Emirates (UAE). Over a dozen experimental vaccines are being trialed across the globe, but China's vaccine is the first one to proceed to phase III human trials.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced the Company has completed business negotiations with one of the U.S. Government's top national security research institutions regarding the acquisition of rights to the Integrated Optical Biosensor System (IBOS) technology developed by the laboratory personnel. Biomagnetics Diagnostics plans to utilize this technology to enter the significantly underserved market for handheld biosensors capable of detecting a broad range of disease-causing viruses, bacteria and fungi.
Ornim, Inc. is pleased to announce the receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the CerOx 3210F monitor. Additionally to its previous clearance for non-invasive monitoring of regional hemoglobin oxygen saturation in the brain or skeletal muscle, the CerOx 3210F is now also intended for use as a non-invasive monitor of blood flow in tissue of adults.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matei T Andreoiu, MD 3300 S Fiske Blvd, Rockledge, FL 32955-4306 Ph: (321) 434-9528 | Matei T Andreoiu, MD 8725 N Wickham Rd Ste 202, Melbourne, FL 32940-2240 Ph: (321) 434-9528 |
News Archive
iMDsoft®, a global leader in hospital-wide clinical information systems, and Dominion, a leading provider of technology solutions in Spain and Latin America, have announced an agreement whereby Dominion will distribute iMDsoft's MetaVision® suite of solutions in Spain.
One of the common side effects of HIV and AIDS is neurocognitive impairments - changes in how fast a person can process information, pay attention, multi-task and remember things - yet there are no adequate tests to screen patients for these problems, according to a new study out of St. Michael's Hospital.
Now, China is ready to run its large-scale phase III clinical trial of its novel coronavirus candidate in the United Arab Emirates (UAE). Over a dozen experimental vaccines are being trialed across the globe, but China's vaccine is the first one to proceed to phase III human trials.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced the Company has completed business negotiations with one of the U.S. Government's top national security research institutions regarding the acquisition of rights to the Integrated Optical Biosensor System (IBOS) technology developed by the laboratory personnel. Biomagnetics Diagnostics plans to utilize this technology to enter the significantly underserved market for handheld biosensors capable of detecting a broad range of disease-causing viruses, bacteria and fungi.
Ornim, Inc. is pleased to announce the receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the CerOx 3210F monitor. Additionally to its previous clearance for non-invasive monitoring of regional hemoglobin oxygen saturation in the brain or skeletal muscle, the CerOx 3210F is now also intended for use as a non-invasive monitor of blood flow in tissue of adults.
› Verified 2 days ago
Dr. Robert C Allen Jr., M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1350 Hickory St, Melbourne, FL 32901 Phone: 321-434-1771 Fax: 321-434-1775 | |
Larry Jackson Landry, MD Urology Medicare: Medicare Enrolled Practice Location: 2200 W Eau Gallie Blvd, Suite 202a, Melbourne, FL 32935 Phone: 321-253-1992 Fax: 321-253-1844 | |
Thomas D Fields, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1223 Gateway Drive, Melbourne, FL 32901 Phone: 321-725-4500 Fax: 321-768-0039 | |
Dr. Steven O Bossinger, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1350 Hickory St, Melbourne, FL 32901 Phone: 321-434-1771 Fax: 321-434-1775 | |
Emily Fell Kelly, MD Urology Medicare: Medicare Enrolled Practice Location: 1223 Gateway Dr Ste 2a, Melbourne, FL 32901 Phone: 321-361-5567 Fax: 321-951-3124 | |
Dr. Douglas P Sorensen, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 200 Michigan Ave, Melbourne, FL 32901 Phone: 321-724-4400 Fax: 321-724-1139 |